Oragenics annual revenue
2010
2011
2012
2013
2014
2015
2016
2017
2021
2022
2023
2024
2025
Oragenics Revenue Growth & History (OGEN)
Oragenics reported $0 in revenue for fiscal 2025.
View full Oragenics company overviewOragenics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | −$37,653 | −100.00% |
| 2023 | 2023-12-31 | $37,653 | −$93,868 | −71.37% |
| 2022 | 2022-12-31 | $131,521 | $44,534 | +51.20% |
| 2021 | 2021-12-31 | $86,987 | — | — |
| 2017 | 2017-12-31 | $0 | $0 | — |
| 2016 | 2016-12-31 | $0 | $0 | — |
| 2015 | 2015-12-31 | $0 | −$939,926 | −100.00% |
| 2014 | 2014-12-31 | $939,926 | −$92,307 | −8.94% |
| 2013 | 2013-12-31 | $1.0M | −$299,531 | −22.49% |
| 2012 | 2012-12-31 | $1.3M | −$112,683 | −7.80% |
| 2011 | 2011-12-31 | $1.4M | $135,537 | +10.35% |
| 2010 | 2010-12-31 | $1.3M | — | — |
Oragenics quarterly revenue
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q4 2023 | 2023-12-31 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $7,466 | −$78,581 | −91.32% |
| Q2 2023 | 2023-06-30 | $13,163 | −$17,228 | −56.69% |
| Q1 2023 | 2023-03-31 | $17,024 | $1,941 | +12.87% |
| Q4 2022 | 2022-12-31 | $0 | — | — |
| Q3 2022 | 2022-09-30 | $86,047 | — | — |
| Q2 2022 | 2022-06-30 | $30,391 | — | — |
| Q1 2022 | 2022-03-31 | $15,083 | — | — |
| Q4 2018 | 2018-12-31 | $0 | $0 | — |
| Q3 2018 | 2018-09-30 | $0 | $0 | — |
| Q2 2018 | 2018-06-30 | $0 | $0 | — |
| Q1 2018 | 2018-03-31 | $0 | $0 | — |
| Q4 2017 | 2017-12-31 | $0 | $0 | — |
| Q3 2017 | 2017-09-30 | $0 | $0 | — |
| Q2 2017 | 2017-06-30 | $0 | $0 | — |
| Q1 2017 | 2017-03-31 | $0 | $0 | — |
| Q4 2016 | 2016-12-31 | $0 | −$240,234 | −100.00% |
| Q3 2016 | 2016-09-30 | $0 | −$329,795 | −100.00% |
| Q2 2016 | 2016-06-30 | $0 | −$242,038 | −100.00% |
| Q1 2016 | 2016-03-31 | $0 | −$363,774 | −100.00% |
| Q4 2015 | 2015-12-31 | $240,234 | $19,730 | +8.95% |
| Q3 2015 | 2015-09-30 | $329,795 | $128,785 | +64.07% |
| Q2 2015 | 2015-06-30 | $242,038 | −$61,714 | −20.32% |
| Q1 2015 | 2015-03-31 | $363,774 | $149,114 | +69.47% |
| Q4 2014 | 2014-12-31 | $220,504 | −$214,280 | −49.28% |
| Q3 2014 | 2014-09-30 | $201,010 | −$52,364 | −20.67% |
| Q2 2014 | 2014-06-30 | $303,752 | $136,084 | +81.16% |
| Q1 2014 | 2014-03-31 | $214,660 | $38,253 | +21.68% |
| Q4 2013 | 2013-12-31 | $434,784 | $4,202 | +0.98% |
| Q3 2013 | 2013-09-30 | $253,374 | −$10,874 | −4.12% |
| Q2 2013 | 2013-06-30 | $167,668 | −$88,739 | −34.61% |
| Q1 2013 | 2013-03-31 | $176,407 | −$204,120 | −53.64% |
| Q4 2012 | 2012-12-31 | $430,582 | $33,992 | +8.57% |
| Q3 2012 | 2012-09-30 | $264,248 | −$86,103 | −24.58% |
| Q2 2012 | 2012-06-30 | $256,407 | −$91,162 | −26.23% |
| Q1 2012 | 2012-03-31 | $380,527 | $30,590 | +8.74% |
| Q4 2011 | 2011-12-31 | $396,590 | — | — |
| Q3 2011 | 2011-09-30 | $350,351 | −$14,223 | −3.90% |
| Q2 2011 | 2011-06-30 | $347,569 | $42,873 | +14.07% |
| Q1 2011 | 2011-03-31 | $349,937 | — | — |
| Q3 2010 | 2010-09-30 | $364,574 | — | — |
| Q2 2010 | 2010-06-30 | $304,696 | — | — |
Oragenics revenue growth trends
Oragenics's latest reported quarter, Q1 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Oragenics source filings ↗